Why the study?
Does pentoxifylline added to cardioplegic solutions reduce myocardial inflammation and ischemia-reperfusion injury in patients undergoing open heart surgery?
Does pentoxifylline added to cardioplegic solutions reduce myocardial inflammation and ischemia-reperfusion injury in patients undergoing open heart surgery?
Adding pentoxifylline to cardioplegic solutions during cardiopulmonary bypass significantly reduces inflammatory markers (IL-6, IL-8, TNF-alpha) and may mitigate ischemia-reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Pentoxifylline in cardioplegia was associated with lower inflammatory markers; leaves open whether it reduces ischemia-reperfusion injury pending randomized trials.
Üstünsoy et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: